Get started
Author

Christopher Lambers

Observed name: Chris Lambers
ORCID: 0000-0001-5866-5417
Observed ORCID: 0000-0001-5866-5417
OpenAlex ID: A5013892237
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
2022 · Martin Kolb, Stylianos E. Orfanos, et al. · Advances in Therapy · 56
PDF
Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis
2019 · Christopher Lambers, Panja M. Boehm, et al. · BioMed Research International · 25
PDF
Glucocorticoid Insensitivity: Is It a Question of Time and Place?
2025 · Christopher Lambers, Michael Roth · Biomedicines · 3
PDF
Zinc Iodide Dimethyl Sulfoxide Reduces Collagen Deposition by Increased Matrix Metalloproteinase-2 Expression and Activity in Lung Fibroblasts
2024 · Michael Roth, Bo Han, et al. · Biomedicines · 3
Bidirectional transfer of human cytomegalovirus strains in donor and recipient seropositive lung transplant patients
2024 · Büsra Külekci, Madlen Mollik, et al. · Journal of Medical Virology · 1
PDF
Chronic Obstructive Pulmonary Disease: Effective treatment with Vasoactive Intestinal Peptide (VIP)
2026 · Wilhelm Mosgoeller *, Ventzislav Petkov, et al. · Clinical Medical Reviews and Reports
PDF
Works count: 6
Citation count: 88
H-index: 3
I10-index: 2
Year
Topic
Type